| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 01/09/2003 | WO2003002546A1 Supported condensation reactants and method for the production thereof |
| 01/09/2003 | WO2003002540A1 Cyclic diamine compound having five-membered cyclic group |
| 01/09/2003 | WO2003002532A1 Cyclic diamine compounds having fused-ring groups |
| 01/09/2003 | WO2003002531A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 01/09/2003 | WO2003002530A2 Pyrrolidines as dipeptidyl peptidase inhibitors |
| 01/09/2003 | WO2003002519A1 Phenol derivatives and their use in medicaments |
| 01/09/2003 | WO2003001913A1 Thiazines and thiazoles for use as material protective agents |
| 01/09/2003 | US20030009033 Substituted condensation products of N-benzyl-3-indenylacent amides with heterocyclic aldehydes for neoplasia |
| 01/09/2003 | US20030008996 Utilized for image forming materials, for example, stereolithography, holography, lithographic printing plate precursors, color proofs, photoresists and color filters, and photosetting resin materials such as ink, paint, adhesive |
| 01/09/2003 | US20030008915 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents |
| 01/09/2003 | US20030008907 Intermediates for the synthesis of benzimidazole derivatives and a process for the preparation thereof |
| 01/09/2003 | US20030008906 Administering benzothiazole compound for therapy, prophylaxis of disease |
| 01/09/2003 | US20030008905 Increasing the capacity of insulin providing cells in an animal by administering to animal a dose of at least one Dipeptidyl-peptidase (DP IV) enzyme activity effector |
| 01/09/2003 | US20030008895 Prostaglandin agonists |
| 01/09/2003 | US20030008884 Fungicidal phenyl (thio) urea and phenyl (thio) carbamate derivatives |
| 01/09/2003 | US20030008829 For therapy and prophylaxis of inflammatory diseases associated with the respiratory tract, such as asthma and allergic rhinitis, immunomediated inflammatory disorders, such as rheumatoid arthritis, conjunctivitis, psoriasis |
| 01/09/2003 | US20030008234 Optical data carrier comprising a cyanine dye as light-absorbent compound in the information layer |
| 01/09/2003 | US20030007941 Method of treating hair loss using thyromimetic compounds |
| 01/09/2003 | CA2450722A1 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 01/09/2003 | CA2424645A1 New use of dipeptidyl peptidase iv inhibitors |
| 01/09/2003 | CA2418543A1 New dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents |
| 01/08/2003 | EP1273572A1 Thiophene substituted piperazines useful in the treatment of benign prostatic hyperplasia |
| 01/08/2003 | EP1273298A2 Ritonavir in combination with an additional HIV protease inhibitor for treating aids |
| 01/08/2003 | EP1272469A1 Naphthalene derivatives and their pharmaceutical use |
| 01/08/2003 | EP1272459A1 7- and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds |
| 01/08/2003 | EP1272456A1 Hydrazide and alkoxyamide angiogenesis inhibitors |
| 01/08/2003 | EP1124819B1 Method of lithiating five-membered heterocycles |
| 01/08/2003 | EP1123284B1 Method for the preparation of citalopram |
| 01/08/2003 | EP1121364B1 Method for producing epothilone b and derivatives thereof |
| 01/08/2003 | EP0996439B1 Beta-alkoxyacrylates against malaria |
| 01/08/2003 | EP0988296B1 Naphthothiazolone derivatives active on the d 3 dopaminergic receptor |
| 01/08/2003 | EP0889033B1 Alpha-substituted benzyl heterocyclic derivatives, intermediates for producing the same, and pesticides containing the same as active ingredient |
| 01/08/2003 | EP0833839B1 Peptidyl heterocycles useful in the treatment of thrombin related disorders |
| 01/08/2003 | CN1390206A Inhibitors of factor Xa |
| 01/08/2003 | CN1390204A Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 01/08/2003 | CN1390196A Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 01/08/2003 | CN1390193A Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 01/08/2003 | CN1389458A P-methylsulfonyl phenylacrylate derivative and its prepn process and anti-inflammatory effect |
| 01/08/2003 | CN1389203A Method for treating hair-dropping using thyromimetic compound |
| 01/07/2003 | US6504031 Enzyme inhibitor such as 6-(2-(1-isopropyl-1,2,3,4-tetrahydro -7-isoquinolinyl)ethenyl)-2-naphthalenecarboximidamide, used as angiogenesis inhibitors; antiarthritic, antiinflammatory and antitumor agents |
| 01/07/2003 | US6503949 Glucagon antagonists/inverse agonists |
| 01/07/2003 | US6503935 Imidazoles and related compounds as α1A agonists |
| 01/07/2003 | US6503929 Nitrate salt of anti-ulcer medicine |
| 01/07/2003 | US6503725 Composition and device for detecting leukocytes in urine |
| 01/07/2003 | CA2143208C Sulfonamide inhibitors of hiv-aspartyl protease |
| 01/03/2003 | WO2003000668A1 Oxa(thia)zolidine compounds, process for preparation thereof and anti-inflammatory agents |
| 01/03/2003 | WO2003000262A1 Vinyl phenyl derivatives as glk activators |
| 01/03/2003 | WO2003000260A1 Thiazolyl amides and their use as antiviral drugs |
| 01/03/2003 | WO2003000259A1 Topical application of thiazolyl amides |
| 01/03/2003 | WO2003000247A1 Carbamates of 2-heterocyclic-1,2-ethanediols |
| 01/03/2003 | WO2003000180A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/03/2003 | WO2002083656A3 5-membered heterocycles, preparation and use thereof as mao inhibitors and lipid peroxidation inhibitors, preparation thereof and use thereof as medicaments |
| 01/03/2003 | WO2002064577A3 Method for preparing compounds derived from thiazolidinedione, oxazolidinedione |
| 01/03/2003 | CA2451543A1 Thiazolyl amides and their use as antiviral drugs |
| 01/03/2003 | CA2450579A1 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/02/2003 | US20030004339 Therapy for benign prostatic hyperplasia |
| 01/02/2003 | US20030004212 Cyclohexylamine derivatives as subtype selective N-Methyl-D-Aspartate antagonists |
| 01/02/2003 | US20030004196 Antiinflamamtory agents; autoimmune disease |
| 01/02/2003 | US20030004181 Disubstituted bicyclic heterocycles, the preparation thereof, and their use as pharmaceutical compositions |
| 01/02/2003 | US20030004138 Hypoglycemic agents; antidiabetic agents; dietetics |
| 01/02/2003 | US20030004136 IL-8 receptor ligands-drugs for inflammatory and autoimmune diseases |
| 01/02/2003 | US20030003396 Reflection, protective or covering layers which can be written on or read by blue, red or infrared light |
| 01/02/2003 | EP1270562A2 Cyclic alpha-amino-gamma-hydroxy-amides, process for their preparation and pharmaceutical compositions thereof |
| 01/02/2003 | EP1268443A1 2-hydroxy-mutilin carbamate derivatives for antibacterial use |
| 01/02/2003 | EP1268430A1 Chemical complex compprising a pyridine carboxy derivative and an h2 histamine receptor antagonist |
| 01/02/2003 | EP1268429A1 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 01/02/2003 | EP1268412A1 Sulphonamido-substituted bridged bicycloalkyl derivatives |
| 01/02/2003 | EP1268401A1 Process for the selective n-formylation of n-hydroxylamines |
| 01/02/2003 | EP1268096A1 Extrusion die |
| 01/02/2003 | EP1073654A4 2,3-olefinic epothilone derivatives |
| 01/02/2003 | EP1073648A4 12,13-modified epothilone derivatives |
| 01/02/2003 | EP1073647A4 12,13-cyclopropane epothilone derivatives |
| 01/02/2003 | EP0751939B9 Naphthylamides as central nervous system agents |
| 01/01/2003 | CN1387849A Use of thiazolidinedione for preventing or retaining non-insulin-dependent diabets mellitus (NIDDM) attack |
| 01/01/2003 | CN1387848A Use of thiazolidinedione for preventing or retaining non-insulin-dependent diabets mellitus (NIDDM) attack |
| 12/31/2002 | US6500832 Administering enzyme inhibitors as viricides for prophylaxis of viral diseases such as aquired immune deficiency syndrome |
| 12/31/2002 | US6500817 Thiazolyl urea derivatives and their utilization as antiviral agents |
| 12/31/2002 | US6500812 Gastrointestinal disorders; antiinflammatory agents |
| 12/31/2002 | US6500804 Administering a dipeptidyl aminopeptidase effector which is selected from the group consisting of n-(n-substituted glycyl)2-cyanopyrrolidones, n-aminoacyl thiazolidines, n-aminoacyl pyrrolidines |
| 12/31/2002 | US6500803 Factor VIIa inhibitors |
| 12/26/2002 | US20020198243 Cyclizing the tert-butyl-thiourea derivative to form the end product |
| 12/26/2002 | US20020198242 Administering to an animal an effective dose of atleast an enzyme Dipeptidyl Peptidase (DP IV) enzyme activity effector to increase the capacity of insulin producing cells |
| 12/26/2002 | US20020198241 Inhibiting bacterial growth in humans and nonhuman mammals by administering to the patient an antibacterially effective dose of hydroxamic acid derivatives containing carbamoyl groups |
| 12/26/2002 | US20020198207 Novel Hexanoic acid derivatives |
| 12/26/2002 | US20020198200 Alpha-acyl- and alpha-heteroatom-substituted benzene acetamide glucokinase activators |
| 12/26/2002 | US20020198184 Matrix metalloproteinase inhibitor is useful as an anticancer agent, angiogenesis inhibitor, a tumor cell infiltration inhibitor or a tumor metastasis inhibitor; inflammatory diseases, osteoarthritis, rheumatoid arthritis |
| 12/26/2002 | US20020195930 Organic electroluminescent materials |
| 12/25/2002 | CN1387519A 2-imino-1,3-thiazine derivs. |
| 12/25/2002 | CN1387518A Heterocyclic substd, diphenyl leukotriene antagonists |
| 12/25/2002 | CN1097049C Processes for preparing intermediate product used in method of diastereoselective synthesis of nucleosides |
| 12/24/2002 | US6498275 Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 12/24/2002 | US6498265 3-amino-2-mercaptobenzoic acid derivatives and processes for their preparation |
| 12/24/2002 | US6498257 2,3-olefinic epothilone derivatives |
| 12/24/2002 | US6498190 Bicyclic amino derivatives and PGD2 antagonist containing the same |
| 12/24/2002 | US6498177 Alpha 2 adrenergic receptor agonist; analgesic, sedative and anaesthetic agents |
| 12/24/2002 | US6498174 Agonists to peroxisome proliferator-activated receptors; modulating blood glucose and lipid levels; reducing dyslipidemia and hyperinsulinemia associated with impaired glucose tolerance or metabolic syndrome |
| 12/24/2002 | US6498172 Prostaglandin agonists and their use to treat bone disorders |
| 12/24/2002 | US6498004 Silver halide light sensitive emulsion layer having enhanced photographic sensitivity |
| 12/24/2002 | CA2150812C Catechol diethers as selective pde iv inhibitors |
| 12/19/2002 | WO2002100977A1 Organic electroluminescence device and luminance material |